Walgreens Boots Alliance (NASDAQ:WBA) Releases Quarterly Earnings Results, Beats Expectations By $0.10 EPS

Walgreens Boots Alliance (NASDAQ:WBA) announced its earnings results on Tuesday. The pharmacy operator reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.10, Zacks reports. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $38.59 billion during the quarter, compared to the consensus estimate of $37.90 billion. During the same period in the prior year, the firm earned $1.20 earnings per share. The business’s quarterly revenue was up 4.1% compared to the same quarter last year.

Walgreens Boots Alliance Trading Up 1.8 %

Shares of NASDAQ WBA opened at $10.78 on Thursday. The firm has a market capitalization of $9.32 billion, a PE ratio of -1.05, a PEG ratio of 1.31 and a beta of 0.67. Walgreens Boots Alliance has a one year low of $8.08 and a one year high of $18.83. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The business has a 50-day moving average price of $10.72 and a two-hundred day moving average price of $10.04.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the stock. StockNews.com initiated coverage on shares of Walgreens Boots Alliance in a research note on Thursday, April 3rd. They issued a “hold” rating for the company. Truist Financial decreased their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Bank of America upped their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and reduced their price objective for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Finally, Royal Bank of Canada raised their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, Walgreens Boots Alliance currently has an average rating of “Hold” and an average price target of $10.59.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.